Literature DB >> 526911

A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

J H Goldie, A J Coldman.   

Abstract

A mathematic model has been developed relating the drug sensitivity of a tumor to its own spontaneous mutation rate towards phenotypic drug resistance. The proportion as well as the absolute numbers of resistant cells will increase with time and the fraction of resistant cells within tumor colonies of the same size with vary depending on whether mutation occurs as an early or late event. Analysis of the model indicates that the probability of the appearance of a resistant phenotype increases with the mutation rate. Furthermore, for any population of tumors with a non-zero mutation rate the likelihood of there being at least one resistant cell will go from a condition of low to high probability over a very short interval in the tumor's biologic history.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526911

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  270 in total

1.  [Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study].

Authors:  J Schütte; N Niederle; W Eberhardt; S Seeber; W Alberti; V Budach; H Hirche; C G Schmidt
Journal:  Klin Wochenschr       Date:  1989-12-04

2.  Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.

Authors:  Regina I Jakacki; Peter C Burger; Tianni Zhou; Emiko J Holmes; Mehmet Kocak; Arzu Onar; Joel Goldwein; Minesh Mehta; Roger J Packer; Nancy Tarbell; Charles Fitz; Gilbert Vezina; Joanne Hilden; Ian F Pollack
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

3.  Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.

Authors:  Joohee Yoon; Eung-Sam Kim; Sung Jong Lee; Chang-Wook Park; Hyung Jin Cha; Bee Hak Hong; Kwan Yong Choi
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

4.  A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance.

Authors:  S Michelson; D Slate
Journal:  Bull Math Biol       Date:  1992-11       Impact factor: 1.758

Review 5.  The concept of dose intensification in the treatment of neoplastic disease.

Authors:  U B Wandl; N Niederle
Journal:  Infection       Date:  1992       Impact factor: 3.553

6.  An elementary approach to modeling drug resistance in cancer.

Authors:  Cristian Tomasetti; Doron Levy
Journal:  Math Biosci Eng       Date:  2010-10       Impact factor: 2.080

Review 7.  Operative management of primary epithelial ovarian cancer.

Authors:  Mario M Leitao; Dennis S Chi
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

8.  Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?

Authors:  Michael Mantatzis; Stylianos Kakolyris; Kyriakos Amarantidis; Anastasios Karayiannakis; Panos Prassopoulos
Journal:  Eur Radiol       Date:  2009-02-24       Impact factor: 5.315

Review 9.  Quantitative genetic analysis of tumor progression.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 10.  Update on the evidence regarding maintenance therapy.

Authors:  Jeong Eun Lee; Chae-Uk Chung
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.